Skip to main content

Table 2 Quality assessment included meta-analysis the association between post-term birth and ASD

From: The association between post-term births and autism spectrum disorders: an updated systematic review and meta-analysis

Studies

Designa

Limitationb

Consistencyc

Directnessd

Inmprecisione

Reporting biasf

Strengthg

Gradienth

Counfoundingi

Quality

Brumbaugh, 2020

Cohort

0

− 1

0

0

0

0

0

 + 1

Low

Leavy, 2012

Cohort

0

− 1

0

0

0

 + 2

 + 1

0

Low

Martini, 2022

Case–control

0

0

0

0

0

 + 1

 + 1

0

Moderate

Xie, 2017

Cohort

0

0

0

0

0

0

 + 1

0

Moderate

Atladottir, 2016

Cohort

0

0

0

0

0

 + 1

 + 1

0

Moderate

Persson, 2020

Cohort

0

0

0

0

0

0

 + 1

 + 1

Moderate

Sugie, 2005

Case–control

0

0

0

0

0

 + 1

 + 1

0

Moderate

Tawfeeq, 2016

Case–control

− 1

0

0

0

0

 + 2

 + 1

0

Low

Zhang, 2010

Case–control

0

− 1

0

− 1

0

 + 1

 + 1

0

Low

Fernandes, 2016

Cross-sectional

− 1

0

 

− 1

0

 + 1

 + 1

0

Low

Al-Ali, 2021

Case–control

0

− 1

0

0

0

0

 + 1

0

Low

Hisle-Gorman, 2018

Case–control

0

− 1

0

0

0

0

0

0

Low

Laxer, 1988

Case–control

− 1

− 1

0

0

0

 + 1

 + 1

0

Low

Rolschau, 2020

Cohort

0

− 1

0

0

0

0

0

0

Low

Cryan, 1996

Case–control

− 1

− 1

0

− 1

0

 + 2

0

0

Low

Lord, 1989

Case–control

− 1

0

0

− 1

0

 + 2

 + 1

0

Low

Gillberg, 1983

Case–control

− 1

0

0

− 1

0

 + 2

 + 1

0

Low

Mason-Brothers, 1990

Case–control

− 1

− 1

0

0

0

0

 + 1

0

Low

  1. Quality of evidence and definitions: high quality: further research is very unlikely to change our confidence in the estimate of effect; moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; Very low quality: any estimate of effect is very uncertain
  2. aRefers to the basic study design, which we have broadly categorized as randomized trials (high), observational (cohort/case–control) studies (low), and other evidence (very low)
  3. bRefers to the detailed study methods and execution [serious (− 1) or very serious (− 2) limitation]
  4. cRefers to the similarity in the estimates of effect across studies [important inconsistency (− 1)]
  5. dRefers to the extent to which the ‘people’, ‘interventions’, and ‘outcome measures’ are similar to those of interest [some (− 1) or major (− 2) uncertainty about directness]
  6. eRefers to imprecise or sparse data (− 1)
  7. fRefers to the high risk of reporting bias (− 1)
  8. gRefers to the strong (relative risk > 2 or < 0.5; + 1) or very strong (relative risk > 5 or < 0.2; + 2) evidence of association with no plausible confounders
  9. hRefers to evidence of a dose–response gradient (+ 1)
  10. IRefers to all plausible confounders that would have reduced the effect (+ 1)